Skip to main content
Log in

Critical Care Guidelines on the Endovascular Management of Cerebral Vasospasm

  • Review
  • Published:
Neurocritical Care Aims and scope Submit manuscript

Abstract

Cerebral vasospasm and delayed cerebral ischemia account for significant morbidity and mortality after aneurysmal subarachnoid hemorrhage. While most patients are managed with triple-H therapy, endovascular treatments have been used when triple-H treatment cannot be used or is ineffective. An electronic literature search was conducted to identify English language articles published through October 2010 that addressed endovascular management of vasospasm. A total of 49 articles were identified, addressing endovascular treatment timing, intra-arterial treatments, and balloon angioplasty. Most of the available studies investigated intra-arterial papaverine or balloon angioplasty. Both have generally been shown to successfully treat vasospasm and improve neurological condition, with no clear benefit from one treatment compared with another. There are reports of complications with both therapies including vessel rupture during angioplasty, intracranial hypertension, and possible neurotoxicity associated with papaverine. Limited data are available evaluating nicardipine or verapamil, with positive benefits reported with nicardipine and inconsistent benefits with verapamil.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Fisher CM, Roberson GH, Ojemann RG. Cerebral vasospasm with ruptured saccular aneurysm: the clinical manifestations. Neurosurgery. 1977;1:245–8.

    Article  PubMed  CAS  Google Scholar 

  2. Heros RC, Zervas NT, Varsos V. Cerebral vasospasm after subarachnoid hemorrhage: an update. Ann Neurol. 1983;14:599–608.

    Article  PubMed  CAS  Google Scholar 

  3. Haley EC Jr, Kassell NF, Torner JC. The international cooperative study on the timing of aneurysm surgery. The North American experience. Stroke. 1992;23:205–14.

    Article  PubMed  Google Scholar 

  4. Longstreth WT Jr, Nelson LM, Koepsell TD, van Belle G. Clinical course of spontaneous subarachnoid hemorrhage: a population-based study in King County, Washington. Neurology. 1993;43:712–8.

    PubMed  Google Scholar 

  5. Egge A, Waterloo K, Sjoholm H, Solberg T, Ingebrigtsen T, Romner B. Prophylactic hyperdynamic postoperative fluid therapy after aneurysmal subarachnoid hemorrhage: a clinical, prospective, randomized, controlled study. Neurosurgery. 2001;49:593–605.

    PubMed  CAS  Google Scholar 

  6. Group GW. Education and debate: grading quality of evidence and strength of recommendations. BMJ. 2004;328:1–8.

    Article  Google Scholar 

  7. Zwienenberg-Lee M, Hartman J, Rudisill N, et al. Effect of prophylactic transluminal balloon angioplasty on cerebral vasospasm and outcome in patients with Fisher grade III subarachnoid hemorrhage: results of a phase II multicenter, randomized, clinical trial. Stroke. 2008;39:1759–65.

    Article  PubMed  Google Scholar 

  8. Rosenwasser RH, Armonda RA, Thomas JE, Benitez RP, Gannon PM, Harrop J. Therapeutic modalities for the management of cerebral vasospasm: timing of endovascular options. Neurosurgery. 1999;44:975–9.

    Article  PubMed  CAS  Google Scholar 

  9. Bejjani GK, Bank WO, Olan WJ, Sekhar LN. The efficacy and safety of angioplasty for cerebral vasospasm after subarachnoid hemorrhage. Neurosurgery. 1998;42:979–86.

    Article  PubMed  CAS  Google Scholar 

  10. Hoh BL, Ogilvy CS. Endovascular treatment of cerebral vasospasm: transluminal balloon angioplasty, intra-arterial papaverine, and intra-arterial nicardipine. Neurosurg Clin N Am. 2005;16:1501–16.

    Article  Google Scholar 

  11. Kassell NF, Helm G, Simmons N, Phillips CD, Cail WS. Treatment of cerebral vasospasm with intra-arterial papaverine. J Neurosurg. 1992;77:848–52.

    Article  PubMed  CAS  Google Scholar 

  12. Kaku Y, Yonekawa Y, Tsukahara T, Kazekawa K. Superselective intra-arterial infusion of papaverine for the treatment of cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg. 1992;77:842–7.

    Article  PubMed  CAS  Google Scholar 

  13. Clouston JE, Numaguchi Y, Zoarski GH, Aldrich EF, Simard JM, Zitnay KM. Intraarterial papaverine infusion for cerebral vasospasm after subarachnoid hemorrhage. Am J Neuroradiol. 1995;6:27–38.

    Google Scholar 

  14. Dalbasti T, Karabiyikoglu M, Ozdamar N, Oktar N, Cagli S. Efficacy of controlled-release papaverine pellets in preventing symptomatic cerebral vasospasm. J Neurosurg. 2001;95:44–50.

    Article  PubMed  CAS  Google Scholar 

  15. Fandino J, Kaku Y, Schuknecht B, Valavanis A, Yonekawa Y. Improvement of cerebral oxygenation patterns and metabolic validation of super selective intraarterial infusion of papaverine for the treatment of cerebral vasospasm. J Neurosurg. 1998;89:93–100.

    Article  PubMed  CAS  Google Scholar 

  16. Firlik KS, Kaufmann AM, Firlik AD, Jungreis CA, Yonas H. Intra-arterial papaverine for the treatment of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Surg Neurol. 1999;51:66–74.

    Article  PubMed  CAS  Google Scholar 

  17. Little N, Morgan MK, Grinnell V, Sorby W. Intra-arterial papaverine in the management of cerebral vasospasm following subarachnoid haemorrhage. J Clin Neurosci. 1994;1:42–6.

    Article  PubMed  CAS  Google Scholar 

  18. Liu JK, Tenner MS, Gottfried ON, et al. Efficacy of multiple intraarterial papaverine infusions for improvement in cerebral circulation time in patients with recurrent cerebral vasospasm. J Neurosurg. 2004;100:414–21.

    Article  PubMed  CAS  Google Scholar 

  19. Morgan MK, Jonker B, Finfer S, Harrington T, Dorsch NW. Aggressive management of aneurysmal subarachnoid haemorrhage based on a papaverine angioplasty protocol. J Clin Neurosci. 2000;7:305–8.

    Article  PubMed  CAS  Google Scholar 

  20. Numaguchi Y, Zoarski GH. Intra-arterial papaverine treatment for cerebral vasospasm: our experience and review of the literature. Neurol Med Chir (Tokyo). 1998;38:189–95.

    Article  CAS  Google Scholar 

  21. Segawa H, Saito I, Okada T, et al. Efficacy of intracisternal papaverine on symptomatic vasospasm. No Shinkei Geka. 1986;14:847–54.

    PubMed  CAS  Google Scholar 

  22. Yoshimura S, Tsukahara T, Hashimoto N, Kazekawa K, Kobayashi A. Intra-arterial infusion of papaverine combined with intravenous administration of high-dose nicardipine for cerebral vasospasm. Acta Neurochir (Wien). 1995;135:186–90.

    Article  CAS  Google Scholar 

  23. Polin RS, Hansen CA, German P, Chadduck JB, Kassell NF. Intra-arterially administered papaverine for the treatment of symptomatic cerebral vasospasm. Neurosurgery. 1998;42:1256–64.

    Article  PubMed  CAS  Google Scholar 

  24. Sawada M, Hashimoto N, Tsukahara T, Nishi S, Kaku Y, Yoshimura S. Effectiveness of intra-arterially infused papaverine solutions of various concentrations for the treatment of cerebral vasospasm. Acta Neurochir (Wien). 1997;139:706–11.

    Article  CAS  Google Scholar 

  25. Smith WS, Dowd CF, Johnston SC, et al. Neurotoxicity of intra-arterial papaverine preserved with chlorobutanol used for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke. 2004;35:2518–22.

    Article  PubMed  CAS  Google Scholar 

  26. Albanese ERA, Quiroga M, Willis RN, Mericle RA, Ulm AJ. Ultrahigh-dose intraarterial infusion of verapamil through an indwelling micro catheter for medically refractory severe vasospasm: initial experience. J Neurosurg. 2010;113:913–22.

    Article  PubMed  CAS  Google Scholar 

  27. Feng L, Fitzsimmons BF, Young WL, et al. Intraarterially administered verapamil as adjunct therapy for cerebral vasospasm: safety and 2-year experience. Am J Neuroradiol. 2002;23:1284–90.

    PubMed  Google Scholar 

  28. Keuskamp J, Murali R, Chao KH. High-dose intraarterial verapamil in the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. J Neurosurg. 2008;108:458–63.

    Article  PubMed  CAS  Google Scholar 

  29. Mazumdar A, Rivet DJ, Derdeyn CP, Cross DT III, Moran CJ. Effect of intraarterial verapamil on the diameter of vasospastic intracranial arteries in patients with cerebral vasospasm. Neurosurg Focus. 2006;21:E15.

    Article  PubMed  Google Scholar 

  30. Badjatia N, Topcuoglu MA, Pryor JC, et al. Preliminary experience with intra-arterial nicardipine as a treatment for cerebral vasospasm. Am J Neuroradiol. 2004;25:819–26.

    PubMed  Google Scholar 

  31. Linfante I, Delgado-Mederos R, Andreone V, Gounis M, Hendricks L, Wakhloo AK. Angiographic and hemodynamic effect of high concentration of intra-arterial nicardipine in cerebral vasospasm. Neurosurgery. 2008;63:1080–6.

    Article  PubMed  Google Scholar 

  32. Tejada JG, Taylor RA, Ugurel MS, Hayakawa M, Lee SK, Chaloupka JC. Safety and feasibility of intra-arterial nicardipine for the treatment of subarachnoid hemorrhage-associated vasospasm: initial clinical experience with high-dose infusions. Am J Neuroradiol. 2007;28:844–8.

    PubMed  CAS  Google Scholar 

  33. Andaluz N, Tomsick TA, Tew JM Jr, van Loveren HR, Yeh HS, Zuccarello M. Indications for endovascular therapy for refractory vasospasm after aneurysmal subarachnoid hemorrhage: experience at the University of Cincinnati. Surg Neurol. 2002;58:131–8.

    Article  PubMed  Google Scholar 

  34. Armonda RA, Thomas JE, Rosenwasser RH. Early and aggressive treatment of medically intractable cerebral vasospasm with pentobarbital coma, cerebral angioplasty and ICP reduction. Neurosurg Focus. 1998;5:e7.

    PubMed  CAS  Google Scholar 

  35. Beck J, Raabe A, Lanfermann H, et al. Effects of balloon angioplasty on perfusion- and diffusion-weighted magnetic resonance imaging results and outcome in patients with cerebral vasospasm. J Neurosurg. 2006;105:220–7.

    Article  PubMed  Google Scholar 

  36. Coyne TJ, Montanera WJ, Macdonald RL, Wallace MC. Percutaneous transluminal angioplasty for cerebral vasospasm after subarachnoid hemorrhage. Can J Surg. 1994;37:391–6.

    PubMed  CAS  Google Scholar 

  37. Elliott JP, Newell DW, Lam DJ, et al. Comparison of balloon angioplasty and papaverine infusion for the treatment of vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg. 1998;88:277–84.

    Article  PubMed  CAS  Google Scholar 

  38. Eskridge JM, McAuliffe W, Song JK, et al. Balloon angioplasty for the treatment of vasospasm: results of first 50 cases. Neurosurgery. 1998;42:510–6.

    Article  PubMed  CAS  Google Scholar 

  39. Eskridge JMND, Pendleton GA. Transluminal angioplasty for treatment of vasospasm. Neurosurg Clin N Am. 1990;1:387–99.

    PubMed  CAS  Google Scholar 

  40. Firlik AD, Kaufmann AM, Jungreis CA, Yonas H. Effect of transluminal angioplasty on cerebral blood flow in the management of symptomatic vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg. 1997;86:830–9.

    Article  PubMed  CAS  Google Scholar 

  41. Fujii Y, Takahashi A, Yoshimoto T. Effect of balloon angioplasty on high grade symptomatic vasospasm after subarachnoid hemorrhage. Neurosurg Rev. 1995;18:7–13.

    Article  PubMed  CAS  Google Scholar 

  42. Higashida RT, Halbach VV, Cahan LD, et al. Transluminal angioplasty for treatment of intracranial arterial vasospasm. J Neurosurg. 1989;71:648–53.

    Article  PubMed  CAS  Google Scholar 

  43. Higashida RT, Halbach VV, Dormandy B, Bell J, Brant-Zawadzki M, Hieshima GB. New microballoon device for transluminal angioplasty of intracranial arterial vasospasm. Am J Neuroradiol. 1990;11:233–8.

    PubMed  CAS  Google Scholar 

  44. Higashida RT, Halbach VV, Dowd CF, Dormandy B, Bell J, Hieshima GB. Intravascular balloon dilatation therapy for intracranial arterial vasospasm: patient selection, technique, and clinical results. Neurosurg Rev. 1992;15:89–95.

    Article  PubMed  CAS  Google Scholar 

  45. Jestaedt L, Pham M, Bartsch AJ, et al. The impact of balloon angioplasty on the evolution of vasospasm-related infarction after aneurysmal subarachnoid hemorrhage. Neurosurgery, in press.

  46. Katoh H, Shima K, Shimizu A, et al. Clinical evaluation of the effect of percutaneous transluminal angioplasty and intra-arterial papaverine infusion for the treatment of vasospasm following aneurysmal subarachnoid hemorrhage. Neurol Res. 1999;21:195–203.

    PubMed  CAS  Google Scholar 

  47. Muizelaar JP, Zwienenberg M, Mini NA, Hecht ST. Safety and efficacy of transluminal balloon angioplasty in the prevention of vasospasm in patients with Fisher grade 3 subarachnoid hemorrhage: a pilot study. Neurosurg Focus. 1998;5:e5.

    Article  PubMed  CAS  Google Scholar 

  48. Muizelaar JP, Zwienenberg M, Rudisill NA, Hecht ST. The prophylactic use of transluminal balloon angioplasty in patients with Fisher grade 3 subarachnoid hemorrhage: a pilot study. J Neurosurg. 1999;91:51–8.

    Article  PubMed  CAS  Google Scholar 

  49. Newell DW, Eskridge JM, Mayberg MR, Grady MS, Winn HR. Angioplasty for the treatment of symptomatic vasospasm following subarachnoid hemorrhage. J Neurosurg. 1989;71:654–60.

    Article  PubMed  CAS  Google Scholar 

  50. Terry A, Zipfel G, Milner E, et al. Safety and technical efficacy of over-the-wire balloons for the treatment of subarachnoid hemorrhage-induced cerebral vasospasm. Neurosurg Focus. 2006;21:E14.

    Article  PubMed  Google Scholar 

  51. Turowski B, de Rochemont R, Beck J, Berkefeld J, Zanella FE. Assessment of changes in cerebral circulation time due to vasospasm in a specific arterial territory: effect of angioplasty. Neuroradiology. 2005;37:134–43.

    Article  Google Scholar 

  52. Zubkov YN, Nikiforov BM, Shustin VA. Balloon catheter technique for dilatation of constricted cerebral arteries after aneurysmal SAH. Acta Neurochir (Wien). 1984;70:65–79.

    Article  CAS  Google Scholar 

  53. Lewis DHPEJ, Newell DW, Eskridge JM, Richard Winn H. Interventional endovascular therapy: SPECT cerebral blood flow imaging compared with transcranial Doppler monitoring of balloon angioplasty and intraarterial papaverine for cerebral vasospasm. J Stroke Cerebrovasc Dis. 1999;8:71–5.

    Article  PubMed  CAS  Google Scholar 

  54. Coenen VA, Hansen CA, Kassell NF, Polin RS. Endovascular treatment for symptomatic cerebral vasospasm after subarachnoid hemorrhage: transluminal balloon angioplasty compared with intraarterial papaverine. Neurosurg Focus. 1998;5:e6.

    Article  PubMed  Google Scholar 

  55. Polin RS, Coenen VA, Hansen CA, et al. Efficacy of transluminal angioplasty for the management of symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg. 2000;92:284–90.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to Brian L. Hoh.

Additional information

The Participants in the International Multi-disciplinary Consensus Conference: Michael N. Diringer, Thomas P. Bleck, Nicolas Bruder, E. Sander Connolly Jr, Giuseppe Citerio, Daryl Gress, Daniel Hanggi, J. Claude Hemphill III MAS, Brian Hoh, Giuseppe Lanzino, Peter Le Roux, David Menon, Alejandro Rabinstein, Erich Schmutzhard, Lori Shutter, Nino Stocchetti, Jose Suarez, Miriam Treggiari, MY Tseng, Mervyn Vergouwen, Paul Vespa, Stephan Wolf, Gregory J. Zipfel.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kimball, M.M., Velat, G.J., Hoh, B.L. et al. Critical Care Guidelines on the Endovascular Management of Cerebral Vasospasm. Neurocrit Care 15, 336–341 (2011). https://doi.org/10.1007/s12028-011-9600-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12028-011-9600-1

Keywords

Navigation